The Global Diabetes Compact framework is a collaborative initiative led by the World Health Organization (WHO) to address the rising global burden of diabetes affecting over 420 million people worldwide. It aims to mobilize international action and resources to scale up prevention, diagnosis, treatment, and care for diabetes, particularly in low- and middle-income countries where the disease prevalence is rapidly increasing.
The Global Diabetes Framework underscores the significant impact of diabetes on health, highlighting the risks of complications such as heart disease and early mortality. The COVID-19 pandemic has further worsened these challenges, disrupting diabetes services and increasing severe cases among those with diabetes.
The Compact aims to reduce diabetes risk, ensure equitable access to treatment, and prevent type 2 diabetes through obesity, unhealthy diet, and physical inactivity. It presents eight key asks, including uniting stakeholders, integrating diabetes care into primary health systems, and improving access to diagnostics and medicines. Three cross-cutting features emphasize the importance of insulin access, resilient health systems, and meaningful engagement of individuals with diabetes.
Through partnerships with governments, civil society, and the private sector, the compact seeks to implement evidence-based interventions, strengthen health systems, and improve access to affordable diabetes care, ultimately working towards the Sustainable Development Goal target of reducing premature mortality from noncommunicable diseases by one-third by 2030.
Overall, the Compact calls for global collaboration to alleviate the burden of diabetes and its complications, emphasizing comprehensive strategies and targets for prevention, treatment, and care.
Comments